FORM-Lab

Frankfurt Orofacial Regenerative Medicine

Publications

You can request fulltext Articles here or get in touch with us via our contact form

2017

  1. Udeabor SE, Adisa AO, Orlowska A, Sader RA, Ghanaati S. Assessment of Programmed Cell Death Proteins in Oral Squamous Cell Carcinoma. African Journal of Biomedical Research 2017 -Accepted.

  2. Adisa AO, Udeabor SE, Orlowska A, Sader RA, Ghanaati S. Evaluation of Tumor Associated Macrophages and Angiogenesis in Ameloblatoma. Journal of Clinical and Diagnostic Research 2017 - Accepted.

  3. Udeabor Samuel E, Adisa Akinyele O, Orlowska Anna, Sader Robert A, Ghanaati Shahram. Tumor Associated Macrophages, Angiogenesis and Tumor Cell Migration in Oral Squamous Cell Carcinoma. Annals of African Medicine 2017 -Accepted.

  4. S. Al-Maawi, A.Orlowska , R. Sader, CJ. Kirkpatrick, S. Ghanaati.(2017) In vivo cellular Reactions to Different Biomaterials – Physiological and Pathological Aspects and their consequences. A Review Article. Seminars in Immunology- doi: 10.1016/j.smim.2017.06.001

      
  5.  J. Lorenz, M. Barbeck, C.J. Kirkpatrick, R. Sader, H. Lerner, S. Ghanaati. (2017) Injectable bone substitute material on the basis of β-TCP and hyaluronan achieves complete bone regeneration while undergoing nearly complete degradation, JOMI -Accepted.
  6. Miron RJ, Zucchelli G, Pikos MA4, Salama M, Lee S, Guillemette V, Fujioka-Kobayashi M Bishara M, Zhang Y, Wang HL, Chandad F, Nacopoulos C, Simonpieri A, Aalam AA, Felice P, Sammartino G, Ghanaati S, Hernandez MA, Choukroun J. Use of platelet-rich fibrin in regenerative dentistry: a systematic review.Clin Oral Investig. 2017 May 27. doi:10.1007/s00784-017-2133-z. [Epub ahead of print].
  7. Dohle E, El Bagdadi K, Sader R, Choukroun J, James Kirkpatrick C, Ghanaati S. (2017). PRF-based matrices to improve angiogenesis in an in vitro co-culture model for bone tissue engineering. J Tissue Eng Regen Med. 2017 May 16. doi: 10.1002/term.2475. [Epub ahead of print]
  8. Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ (2017). Behavior of Gingival Fibroblastson Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP. Int JMol Sci. 2017 Feb 4;18(2). pii: E331.
  9.  Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ (2017). Effects of an injectableplatelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 2017 Mar 29:1-8.
  10.  Choukroun J, Ghanaati S (2017). Reduction of relative centrifugation force within injectableplatelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, plateletsand growth factors: the first introduction to the low speed centrifugation concept. Eur JTrauma Emerg Surg. doi: 10.1007/s00068-017-0767-9. [Epub ahead of print].
  11.  Von der Grün J, Tahtali A, Ghanaati S, Rödel C, Balermpas P (2017). Diagnostic andTreatment Modalities for Patients with Cervical Lymph Node Metastases of Unknown PrimarySite - Current Status and Challenges. Radiation Oncology- doi: 10.1186/s13014-017-0817-9
  12.  El Bagdadi K, Kubesch A, Yu X, Al-Maawi S, Orlowska A, Dias A, Booms P, Dohle E, SaderR, Kirkpatrick CJ, Choukroun J, Ghanaati S (2017). Reduction of relative centrifugal forcesincreases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proofof concept of LSCC (low speed centrifugation concept). Eur J Trauma Emerg Surg. doi:10.1007/s00068-017-0785-7. [Epub ahead of print].
  13.  Barbeck M, Booms P, Unger R, Hoffmann V, Sader R, Kirkpatrick CJ, Ghanaati S (2017)Multinucleated giant cells in the implant bed of bone substitutes are foreign body giant cells-New insights into the material-mediated healing process. Journal of Biomedical MaterialsResearch Part A, 1105-1111.
  14.  Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, ChoukrounJ (2017). Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?Clin Oral invetig. doi: 10.1007/s00784-017-2063-9 [Epub ahead of print].



    2016

  15.  Schwarz F, Mihatovic I, Ghanaati S, Becker J (2016). Performance and safety ofcollagenated xenogeneic bone block for lateral alveolar ridge augmentation and stagedimplant placement. A monocenter, prospective single arm clinical study. Clinical oralimplants research 00, 2016, 1–7.
  16.  Lorenz J, Eichler K, Barbeck M, Lerner H, Stübinger S, Seipel C, Vogl TJ, Kovács AF,Ghanaati S, Sader RA (2016). Volumetric analysis of bone substitute material performancewithin the human sinus cavity of former head and neck cancer patients: A prospective, randomizedclinical trial. Ann Maxillofac Surg. 175-181.
  17.  Adisa AO, Udeabor SE, Kubesch A, Barbeck M, Ghanaati S. (20116). The utility of azan trichromestaining in Ameloblastoma. Niger Postgrad Med J. 2016 Jan-Mar;23(1):44-6.
  18.  Nguyen DH, Pham VTH, Al Kobaisi M, Bhadra C, Orlowska A, Ghanaati S, ManziBM, Baulin VA, Joudkazis S, Kingshott P, Crawford RJ, Ivanova EP .(2016) Adsorption ofHuman Plasma Albumin and Fibronectin onto Nanostructured Black Silicon Surfaces.Langmuir 32, 10744–10751.
  19.  Pham VTH, Truong VK, Orlowska A, Ghanaati S, Barbeck M, Booms P, Fulcher AJ, BhadraCM, Buividas R, Baulin V, Kirkpatrick CJ, Doran P, Mainwaring DE, Juodkazis S, CrawfordRJ, Ivanova EP (2016). “Race for the Surface”: Eukaryotic Cells Can Win. ACS Applied Materials& Interfaces 8, 22025–22031.
  20.  Marsano A, Medeiros da Cunha CM, Ghanaati S, Gueven S, Centola M, Tsaryk R, BarbeckM, Stuedle C, Barbero A, Helmrich U, Schaeren S, Kirkpatrick JC, Banfi A, Martin I (2016).Spontaneous In Vivo Chondrogenesis of Bone Marrow-Derived Mesenchymal ProgenitorCells by Blocking Vascular Endothelial Growth Factor Signaling Stem Cells Transl Med.sctm. 2015-0321.
  21.  Barbeck M, Unger RE, Booms P, Dohle E, Sader RA, Kirkpatrick CJ, Ghanaati S (2016).Monocyte preseeding leads to an increased implant bed vascularization of biphasic calciumphosphate bone substitutes via vessel maturation. J Biomed Mater Res A. 2928-2935 [Epubahead of print].
  22.  Holländer J, Lorenz J, Stübinger S, Hölscher W, Heidemann D, Ghanaati S, Sader R(2016). Zirconia Dental Implants: Investigation of Clinical Parameters, Patient Satisfaction,and Microbial Contamination. Int J Oral Maxillofac Implants. 855-864
  23.  Lorenz J, Blume M, Barbeck M, Teiler A, Kirkpatrick CJ, Sader RA, Ghanaati S (2016). Expansionof the peri-implant attached gingiva with a three-dimensional collagen matrix inhead and neck cancer patients-results from a prospective clinical and histological study.Clin Oral Investig. 1103-1111 [Epub ahead of print].
  24.  Lorenz J, Barbeck M, Sader RA, Kirkpatrick CJ, Russe P, Choukroun J, Ghanaati S (2016).Foreign Body Giant Cell-Related Encapsulation of a Synthetic Material Three Years AfterAugmentation. J Oral Implantol. 273-7 [Epub 2016 Jan 29].
  25.  Smeets R, Barbeck M, Hanken H, Fischer H, Lindner M, Heiland M, Wöltje M, Ghanaati S,Kolk A (2016). Selective laser-melted fully biodegradable scaffold composed of poly(d,llactide)and β-tricalcium phosphate with potential as a biodegradable implant for complexmaxillofacial reconstruction: In vitro and in vivo results. J Biomed Mater Res B Appl Biomater00B:000–000.



    2015

  26.  Barbeck M, Hoffmann C, Sader R, Peters F, Hübner WD, Kirkpatrick CJ, Ghanaati S(2015). Injectable Bone Substitute Based on β-TCP Combined With a Hyaluronan ContainingHydrogel Contributes to Regeneration of a Critical Bone Size Defect Towards Restitutioad Integrum. J Oral Implantol.127-37.
  27.  Ghanaati S, Kovács A, Barbeck M, Lorenz J, Teiler A, Sadeghi N, Kirkpatrick CJ, Sader R(2015). Bilayered, non-cross-linked collagen matrix for regeneration of facial defects afterskin cancer removal: a new perspective for biomaterial-based tissue reconstruction. J CellCommun Signal 3-15.
  28.  Kokkinopoulou M, Spiecker L, Messerschmidt C, Barbeck M, Ghanaati S, Landfester K,Markl J (2015). On the Ultrastructure and Function of Rhogocytes from the Pond SnailLymnaea stagnalis. PLoS One 10(10):e0141195.
  29.  Adisa AO, Udeabor SE, Adeyemi BF, Alica K, Booms P, Ghanaati S, Sader RA (2015). Relative expression of α-smooth muscle actin and matrix metalloproteinases-2 in ameloblastoma
    of a black African sub-population. Ann Afr Med.188-92.
  30.  Udeabor SE, Adisa AO, Lawal AO, Barbeck M, Booms P, Sader RA, Ghanaati S (2015). PTCH-1 and MdM2 expression in ameloblastoma from a West African sub-population: implication for chemotherapeutics. Panafrican Journal of Medicine; 20: 140.
  31.  Schulze B, Meissner M, Ghanaati S, Burck I, Rödel C, Balermpas P (2015). Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck : First clinical experience with vismodegib for locally advanced disease. StrahlentheOnkol. 192(1):25-31 [Epub ahead of print].
  32.  Barbeck M, Motta A, Migliaresi C, Sader R, Kirkpatrick CJ, Ghanaati S (2015). Heterogeneity of biomaterial-induced multinucleated giant cells: Possible importance for the regeneration process? J Biomed Mater Res A. 30 [Epub ahead of print].
  33.  Booms P, Harth M, Sader R, Ghanaati S (2015). Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome. Ann Maxillofac Surg.14-9.
  34.  Barbeck M, Najman S, Stojanović S, Mitić Ž, Živković JM, Choukroun J, Kovačević P, Sader R, Kirkpatrick CJ, Ghanaati S (2015). Addition of blood to a phycogenic bone substitute leads to increased in vivo vascularization. Biomed Mater. 11;10(5):055007.
  35.  Dornoff N, Weiß C, Rödel F, Wagenblast J, Ghanaati S, Nateghian A, Rödel C, Balermpas P (2015). Erratum to: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck. Strahlenther Onkol. 191(9):763-4.
  36. Barbeck M, Dard M, Kokkinopoulou M, Markl J, Booms P, Sader RA, Kirkpatrick CJ, Ghanaati S (2015). Small-sized granules of biphasic bone substitutes support fast implant bed vascularization. Biomatter. e1056943.
  37. Dornoff N, Weiß C, Rödel F, Wagenblast J, Ghanaati S, Atefeh N, Rödel C, Balermpas P (2015). Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck. Strahlenther Onkol. 191(8):656-64.4.
  38.  Tsaryk R, Gloria A, Russo T, Anspach L, De Santis R, Ghanaati S, Unger RE, Ambrosio L, Kirkpatrick CJ (2015). Collagen-low molecular weight hyaluronic acid semi-interpenetrating network loaded with gelatin microspheres for cell and growth factor delivery for nucleus pulposus regeneration. Acta Biomater. 20:10-21.
  39.  Serrano C, García-Fernández L, Fernández-Blázquez JP, Barbeck M, Ghanaati S, Unger R, Kirkpatrick J, Arzt E, Funk L, Turón P, del Campo A (2015). Nanostructured medical sutures with antibacterial properties. Biomaterials. 52:291-300.
  40.  Antunes JC, Tsaryk R, Gonçalves RM, Pereira CL, Landes C, Brochhausen C, Ghanaati S, Barbosa MA, Kirkpatrick CJ (2015). Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells. Tissue Eng Part A. 21(11-12):1869-85.
  41.  Barbeck M, Udeabor SE, Lorenz J, Kubesch A, Choukroun J, Sader RA, Kirkpatrick CJ, Ghanaati S (2014). Induction of multinucleated giant cells in response to small sized bovine bone substitute (Bio-Oss™) results in an enhanced early implantation bed vascularization. Ann Maxillofac Surg. 4(2):150-7.
  42.  Barbeck M, Lorenz J, Kubesch A, Böhm N, Booms P, Choukroun J, Sader R, Kirkpatrick CJ, Ghanaati S (2015). Porcine Dermis-Derived Collagen Membranes Induce Implantation Bed Vascularization Via Multinucleated Giant Cells: A Physiological Reaction? J Oral Implantol. Dec;41(6):e238-51. (IF= 1,432).
  43.  Boehle AP, Herrmann E, Ghanaati S, Ballon A, Landes CA (2015). Transoral vs. extraoral approach in the treatment of condylar  neck fractures. J Craniomaxillofac Surg. Mar;43(2):224-31.
  44.  Lorenz J, Kubesch A, Korzinskas T, Barbeck M, Landes C, Sader RA, Kirkpatrick CJ, Ghanaati S (2015). TRAP-Positive Multinucleated Giant Cells Are Foreign Body Giant Cells Rather Than Osteoclasts: Results from a Split-Mouth Study in Humans. J Oral Implantol. Dec;41(6):e257-66.
  45.  Barbeck M, Lorenz J, Holthaus MG, Raetscho N, Kubesch A, Booms P, Sader R, Kirkpatrick CJ, Ghanaati S (2015). Porcine Dermis and Pericardium-Based, Non-Cross-Linked Materials Induce Multinucleated Giant Cells After Their In Vivo Implantation: A Physiological Reaction? J Oral Implantol. 41(6):e267-81.



    2014

  46.  Tsaryk R, Silva-Correia J, Oliveira JM, Unger RE, Landes C, Brochhausen C, Ghanaati S, Reis RL, Kirkpatrick CJ (2014). Biological performance of cell-encapsulated methacrylated gellan gum-based hydrogels for nucleus pulposus regeneration. J Tissue Eng Regen Med. [Epub ahead of print].
  47.  Willershausen I, Wolf T, Weyer V, Sader R, Ghanaati S, Willershausen B (2014). Influence of E-smoking liquids on human periodontal ligament fibroblasts. Head Face Med.15;10:39.
  48.  Barbeck M, Udeabor S, Lorenz J, Schlee M, Grosse Holthaus M, Raetscho N, Choukroun J, Sader R, Kirkpatrick CJ, Ghanaati S (2014). High-temperature sintering of xenogeneic bone substitutes leads to increased multinucleated giant cell formation: In vivo and preliminary clinical results. J Oral Implantol.
  49.  Balermpas P, Rödel F, Liberz R, Oppermann J, Wagenblast J, Ghanaati S, Harter PN, Mittelbronn M, Weiss C, Rödel C, Fokas E (2014). Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences. Br J Cancer. [Epub ahead of print].
  50.  Kokkinopoulou M, Güler MA, Lieb B, Barbeck M, Ghanaati S, Markl J (2014). 3Dultrastructure, functions and stress responses of gastropod (Biomphalaria glabrata) rhogocytes. PLoS One. 27;9(6):e101078.
  51.  Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, Landes C, Sader R, Kirkpatrick C, Choukroun J (2014). Advanced Platelet-Rich Fibrin (A-PRF) - A new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. [Epubahead of print].
  52.  Udeabor SE, Adisa AO, Kolude B, Barbeck M, Kirkpatrick CJ, Sader RA, Ghanaati S (2014). Expression of CD34 and Maspin in ameloblastoma from a West African subpopulation. Tumour Biol. [Epub ahead of print].
  53.  Ghanaati S, Barbeck M, Booms P, Lorenz J, Kirkpatrick CJ, Sader RA (2014). Potential lack of "standardized" processing techniques for production of allogeneic and xenogeneic bone blocks for application in humans. Acta Biomater. Apr 22. pii: S1742-7061(14)00185-8. [Epub ahead of print].
  54.  Landes C, Ballon A, Ghanaati S, Tran A, Sader R (2014). Treatment of Malar and Midfacial
    Fractures With Osteoconductive Forged Unsintered Hydroxyapatite and Poly-L-Lactide
    Composite Internal Fixation Devices. J Oral Maxillofac Surg. Feb 21. pii: S0278-
    2391(14)00238-9. [Epub ahead of print].
  55.  Willershausen I, Barbeck M, Boehm N, Sader RA, Willershausen B, Kirkpatrick CJ, Ghanaati S (2014). Non-cross-linked collagen type I/III materials enhance cell adhesion and proliferation: In vitro, in vivo and ex vivo studies. J Appl Oral Sci. 2; 22(1):29-37.
  56.  Landes CA, Ballon A, Tran A, Ghanaati S, Sader R (2014). Segmental stability in orthognathic surgery: Hydroxyapatite/Poly-l-lactide osteoconductive composite versus titanium miniplate osteosyntheses. J Craniomaxillofac Surg. 21. pii: S1010-5182(14)00014-6.
  57.  Ghanaati S, Lorenz J, Obreja K, Choukroun J, Landes C, Sader R (2014). Nanocrystaline hydroxyapatatite-based material contributes to implant stability already after three month: A Clinical and radiological 3 year follow- up investigation. J Oral Implantol. 40(1):103-9.



    2013

  58.  Landes C, Korzinskas T, Dehner JF, Santo G, Ghanaati S, Sader R (2013). One-stage microvascular mandible reconstruction and alloplastic TMJ prosthesis. J Craniomaxillofac Surg. 2014 42(1):28-34.
  59.  Landes C, Ballon A, Ghanaati S, Ebel D, Ulrich D, Spohn U, Heunemann U, Sader R, Jaeger R (2013). Evaluation of the Fatigue Performance and Degradability of Resorbable PLDLLA-TMC Osteofixations. Open Biomed Eng J. 29;7:133-46.
  60.  Kirkpatrick CJ, Ramzan Rangoonwala R, Reshetnykov M, Barbeck M, Ghanaati S (2013). Non-Equivalence of Antibiotic Generic Drugs and Risk for Intensive Care Patients. Pharmaceut Reg Affairs 10.4172/2167-7689.1000108.
     
  61.  Ravarian R, Zhong X, Barbeck M, Ghanaati S, Kirkpatrick CJ, Chrzanowski W, Dehghani F (2013). Poly(methyl methacrylate)-Bioglass Class II Hybrid With Enhanced Physical Properties and Biological Activity. ACS Nano. 22;7(10):8469-83.
  62.  Ghanaati S, Barbeck M, Lorenz J, Stuebinger S, Seitz O, Landes C, Kovács A, Kirkpatrick CJ, Sader R (2013). Synthetic bone substitute material comparable to xenogeneic material for bone tissue regeneration in oral cancer patients: first and preliminary histological, histomorphometrical and clinical results, Ann Maxillofac Surg. 3(2):126-38.
  63.  Landes CA, Ghanaati S, Ballon A, Thai VD, Reinhard R, Nolte D, Piwowarczyk A, Wagner M, Sader R (2013). Severely Scarred Oronasal Cleft Defects in Edentulous Adults: Initial Data on the Long-Term Outcome of Telescoped Obturator Prostheses Supported by Zygomatic Implants. Cleft Palate Craniofac J. 50(4):e74-83.
  64. Ghanaati S, Udeabor SE, Barbeck M, Willershausen I, Kuenzel O, Sader RA, Kirkpatrick CJ (2013). Implantation of silicon dioxide-based nanocrystalline hydroxyapatite and pure phase beta-tricalciumphosphate bone substitute granules in caprine muscle tissue does not induce new bone formation. Head Face Med.


    2012

  65.  Ghanaati S (2012). Non-cross-linked porcine-based collagen I-III membranes do not require high vascularization rates for their integration within the implantation bed: a paradigm shift. Acta Biomater; 8 (8): 3061-72.
  66.  Willershausen I, Lehmann KM, Roβ A, Ghanaati S, Willershausen B (2012). Influence of three scan spray systems on human gingival fibroblasts. Quintessence Int; 43 (6): e67-72.
  67.  Schlee M*, Ghanaati S*, Willershausen I, Stimmlmayr M, Sculean A, Sader RA (2012). Bovine pericardium based non-cross linked collagen matrix for successful root coverage, a clinical study in human. Head Face Med; 8 (): 6. (*equally contributed).
  68.  Ghanaati S, Barbeck M, Detsch R, Deisinger U, Hilbig U, Rausch V, Sader R, Unger RE, Ziegler G, Kirkpatrick CJ (2012). The chemical composition of synthetic bone substitutes influences tissue reactions in vivo: histological and histomorphometrical analysis of the cellular inflammatory response to hydroxyapatite, beta-tricalcium phosphate and biphasic calcium phosphate ceramics. Biomed Mater; 7 (1): 015005.
  69.  Ghanaati S, Barbeck M, Willershausen I, Thimm B, Stuebinger S, Korzinskas T, Obreja K, Landes C, Kirkpatrick CJ, Sader RA (2012). Nanocrystalline Hydroxyapatite Bone Substitute Leads to Sufficient Bone Tissue Formation Already after 3 Months: Histological and Histomorphometrical Analysis 3 and 6 Months following Human Sinus Cavity Augmentation. Clin Implant Dent Relat Res. 17. doi: 10.1111/j.1708-8208.2011.00433.x.
  70.  Landes CA, Bündgen L, Laudemann K, Ghanaati S, Sader R (2012). Patient Satisfaction After Prosthetic Rehabilitation of Bone-Grafted Alveolar Clefts With Nonsubmerged ITI Straumann Dental Implants Loaded at Three Months. Cleft Palate Craniofac J ; 49 (5): 601-8.



    2011

  71.  Ghanaati S*, Unger RE*, Webber MJ, Barbeck M, Orth C, Kirkpatrick JA, Booms P, Motta A, Migliaresi C, Sader RA, Kirkpatrick CJ (2011). Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells. Biomaterials; 32 (32): 8150-60. (*equally contributed).
  72.  Ghanaati S*, Barbeck M*, Hilbig U, Hoffmann C, Unger RE, Sader RA, Peters F, Kirkpatrick CJ (2011). An injectable bone substitute composed of beta-tricalcium phosphate granules, methylcellulose and hyaluronic acid inhibits connective tissue influx into its implantation bed in vivo. Acta Biomater; 7 (11): 4018-28. (equally contributed).
  73.  Ghanaati S*, Fuchs S*, Webber MJ, Orth C, Barbeck M, Gomes ME, Reis RL, Kirkpatrick CJ. (2011). Rapid vascularization of starch-poly(caprolactone) in vivo by outgrowth endothelial cells in co-culture with primary osteoblasts. J Tissue Eng Regen Med; 5 (6): e136-43. (*equally contributed).
  74.  Ghanaati S, Schlee M, Webber MJ, Willershausen I, Barbeck M, Balic E, Görlach C, Stupp SI, Sader RA, Kirkpatrick CJ (2011). Evaluation of the tissue reaction to a new bilayered collagen matrix in vivo and its translation to the clinic. Biomed Mater; 6 (1): 015010.



    2010

  75.  Ghanaati S*, Willershausen I*, Barbeck M, Unger RE, Joergens M, Sader RA, Kirkpatrick CJ, Willershausen B (2010). Tissue reaction to sealing materials: different view at biocompatibility. Eur J Med Res; 15 (11): 483-92. (*equally contributed).
  76.  Ghanaati S, Barbeck M, Orth C, Willershausen I, Thimm BW, Hoffmann C, Rasic A, Sader RA, Unger RE, Peters F, Kirkpatrick CJ (2010). Influence of β-tricalcium phosphate granule size and morphology on tissue reaction in vivo. Acta Biomater; 6 (12): 4476-87.
  77.  Unger RE*, Ghanaati S*, Orth C, Sartoris A, Barbeck M, Halstenberg S, Motta A, Migliaresi C, Kirkpatrick CJ (2010). The rapid anastomosis between prevascularized networks on silk fibroin scaffolds generated in vitro with cocultures of human microvascular endothelial and osteoblast cells and the host vasculature. Biomaterials; 31 (27): 6959-67.(*equally contributed).
  78.  Ghanaati S, Orth C, Barbeck M, Willershausen I, Thimm BW, Booms P, Stübinger S, Landes C, Sader RA, Kirkpatrick CJ (2010). Histological and histomorphometrical analysis of a silica matrix embedded nanocrystalline hydroxyapatite bone substitute using the subcutaneous implantation model in Wistar rats. Biomed Mater; 5 (3): 035005.
  79.  Ghanaati S*, Thimm BW*, Unger RE, Orth C, Kohler T, Barbeck M, Müller R, Kirkpatrick CJ (2010). Collagen-embedded hydroxylapatite-beta-tricalcium phosphate-silicon dioxide bone substitute granules assist rapid vascularization and promote cell growth. Biomed Mater; 5 (2): 25004. (equally contributed).
  80.  Ghanaati S*, Orth C*, Unger RE, Barbeck M, Webber MJ, Motta A, Migliaresi C, James Kirkpatrick C (2010). Fine-tuning scaffolds for tissue regeneration: effects of formic acid processing on tissue reaction to silk fibroin. J Tissue Eng Regen Med ; 4 (6): 464-72.(*equally contributed).
  81.  Seitz O, Harth M, Ghanaati S, Lehnert T, Vogl TJ, Sader R, Klein CM (2010). Secondary mandibular reconstruction after oral squamous cell carcinoma resection: clinical reevaluation of transport disk distraction osteogenesis. J Craniofac Surg; 21 (1): 59-63.


    2009

  82.  Ghanaati S*, Webber MJ*, Unger RE, Orth C, Hulvat JF, Kiehna SE, Barbeck M, Rasic A, Stupp SI, Kirkpatrick CJ (2009). Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers. Biomaterials; 30 (31): 6202-12. (*equally contributed).
  83.  Joachim SC, Grus FH, Kraft D, White-Farrar K, Barnes G, Barbeck M, Ghanaati S, Cao S, Li B, Wax MB (2009). Complex antibody profile changes in an experimental autoimmune glaucoma animal model. Invest Ophthalmol Vis Sci; 50 (10): 4734-42.
  84.  Stübinger S*, Ghanaati S*, Saldamli B, Kirkpatrick CJ, Sader R (2009). Er:YAG laser osteotomy: preliminary clinical and histological results of a new technique for contact-free bone surgery.Eur Surg Res.;42(3):150-6. (IF=0, 750). (*equally contributed).
  85.  Stübinger S*, Ghanaati S*, Orth C, Hilbig U, Saldamli B, Biesterfeld S, Kirkpatrick CJ, Sader RA (2009). Maxillary sinus grafting with a nano-structured biomaterial: preliminary clinical and histological results. Eur Surg Res. 42(3):143-9.(*equally contributed).
  86.  Fuchs S, Jiang X, Schmidt H, Dohle E, Ghanaati S, Orth C, Hofmann A, Motta A, Mgliaresi C, Kirkpatrick CJ (2009). Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials; 30 (7): 1329-38.
  87.  Fuchs S*, Ghanaati S*, Orth C, Barbeck M, Kolbe M, Hofmann A, Eblenkamp M, Gomes M, Reis RL, Kirkpatrick CJ (2009). Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials; 30 (4): 526-34.(*equally contributed).